| AIHD | acquired immune hemolytic disease |
|---|---|
| CIC | cardioinhibitor center; circulating immune complex; clean intermittent catheterization; completely i... |
| CMIR | cell-mediated immune response |
| HIB | heart infusion broth; hemolytic immune body; Hemophilus influenzae type B [vaccine] |
| HTIG | human tetanus immune globulin |
| immune sera | Serum that contains antibodies. It is obtained from an animal that has been immunised either by antigen injection or infection with microorganisms containing the antigen. (12 Dec 1998) |
|---|---|
| immune serum | Blood serum containing antibodies. (14 Nov 1997) |
| immune serum globulin | A sterile solution of globulin's that contains many antibodies normally present in adult human blood; a passive immunizing agent frequently used for prophylaxis against hepatitis A. (05 Mar 2000) |
| immune suppression | Suppression of the immune response by some compound or agent. (05 Mar 2000) |
| immune surveillance | <immunology> The hypothesis that lymphocyte traffic ensures that all or nearly all parts of the vertebrate body are surveyed by visiting lymphocytes in order to detect any altered self material, for example mutant cells. (18 Nov 1997) |
| immune system | <immunology> The body system, made up of many organs and cells, that defends the body against infection, disease and foreign substances. The immune system is often stimulated in specific ways to fight cancer cells. (16 Dec 1997) |
| immune thrombocytopenia | Thrombocytopenia associated with antiplatelet antibodies. See: isoimmune neonatal thrombocytopenia, autoimmune neonatal thrombocytopenia. (05 Mar 2000) |
| immune thrombocytopenic purpura | <haematology> A low number of platelets in the blood, which is common in people with HIV, but often resolves as immune deficiency worsens. HIV-related ITP usually does not have serious consequences. Its cause has not been definitely determined. Treatment with AZT frequently alleviates the condition. (09 Oct 1997) |
| immune tolerance | The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (foetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc. (12 Dec 1998) |
| tetanus immune globulin | <protein> A protein antibody to tetanus toxin, given as passive immunity for those lacking any prior tetanus vaccination. (27 Sep 1997) |
| zoster immune globulin | A globulin fraction of pooled plasma from individuals who have recovered from herpes zoster; used prophylactically and therapeutically for varicella. (05 Mar 2000) |
| administration, oral | The giving of drugs, chemicals, or other substances by mouth. (12 Dec 1998) |
| cancer, oral | Cancer of the mouth area. A sore in the mouth that does not heal can be a warning sign of oral cancer. A biopsy is the only to know whether as abnormal area in the oral cavity is cancer. Oral cancer is caused by tobacco (smoking and chewing) and alcohol use. Surgery to remove the tumour in the mouth is the usual treatment for patients with oral cancer. (12 Dec 1998) |
| candidiasis, oral | Infection of the mucous membranes of the mouth by a fungus of the genus candida. (12 Dec 1998) |
| canine oral papilloma | Warts affecting mucous membranes of young dogs; caused by a papillomavirus. (05 Mar 2000) |